🇺🇸 FDA
Patent

US 9051312

Methods of treating dyskinesia and related disorders

granted A61KA61K31/198A61K31/4245

Quick answer

US patent 9051312 (Methods of treating dyskinesia and related disorders) held by Melior Discovery, Inc. expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Melior Discovery, Inc.
Grant date
Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/198, A61K31/4245, A61K31/4439, A61K31/501